Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,214 | -29,397 | -118,513 | -85,474 | -88,441 |
| Depreciation Amortization | -105 | 95 | 1,934 | 1,934 | 2,415 |
| Accounts receivable | N/A | N/A | 436 | -3,301 | 102 |
| Other Working Capital | 508 | 8,641 | 10,275 | -12,924 | 5,263 |
| Other Operating Activity | -5,688 | 2,356 | 13,790 | 21,035 | 20,574 |
| Operating Cash Flow | $-23,499 | $-18,305 | $-92,078 | $-78,730 | $-60,087 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,084 | N/A | 45,836 | 128,750 | -4,782 |
| PPE Investments | N/A | N/A | -2,375 | -43 | 31 |
| Investing Cash Flow | $-10,084 | $N/A | $43,461 | $128,707 | $-4,751 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 28,298 | N/A | N/A | N/A |
| Common Stock Issued | 532 | 5 | 1,677 | 311 | 46,608 |
| Other Financing Activity | 22,171 | -1,303 | 36,474 | 0 | 0 |
| Financing Cash Flow | $22,703 | $27,000 | $38,151 | $311 | $46,608 |
| Beginning Cash Position | 31,614 | 22,919 | 64,149 | 13,861 | 32,091 |
| End Cash Position | 20,734 | 31,614 | 53,683 | 64,149 | 13,861 |
| Net Cash Flow | $-10,880 | $8,695 | $-10,466 | $50,288 | $-18,230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,499 | -18,305 | -92,078 | -78,730 | -60,087 |
| Capital Expenditure | N/A | N/A | -2,375 | -43 | -39 |
| Free Cash Flow | -23,499 | -18,305 | -94,453 | -78,773 | -60,126 |